Skip to main content

Table 3 HBeAg Seroconversion and Loss by Pretreatment ALT Level

From: High rates of early HBeAg seroconversion and relapse in Indian patients of chronic hepatitis B treated with Lamivudine: results of an open labeled trial

 

HbeAg Seroconversion

HBeAg Loss

ALT Level

Number

%

Number

%

<= 1 × ULN

0/10

-

3/10

30

>1-<=2 × ULN

6/20

30

10/20

50

>2-<=5 × ULN

11/20

55

14/20

70

> 5 × ULN

7/10

70

8/10

80

Total

24/60

40

35/60

58.3

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us